satetraxetan
reagin
muromonab
anti-nuclear factor
sintilimab
solitomab
toripalimab
pozelimab
retifanlimab
ziltivekimab
zenocutuzumab
sasanlimab
vanucizumab
dinutuximab
radioimmunoconjugate
antinucleosome
monoantibody
-mab
gevokizumab
abagovomab
olaratumab
brolucizumab
pidilizumab
ravulizumab
tislelizumab
antinucleotide
radioimmunoelectrophoresis
amatuximab
tigatuzumab
-toxa-
radioimmunoprecipitate
amlitelimab
antiplasma
heterophile
Ab
bococizumab
volociximab
antiantibody
atezolizumab
cergutuzumab
afutuzumab
antinucleoside
radioimmunochemistry
radioimmunology
-o-
radioimmunotherapy
chromobody
immunoscintigraphy
mogamulizumab
-les-